German hope for endometrial and ovarian cancer sufferers
This article was originally published in Clinica
Executive Summary
Too many German women die unnecessarily because ovarian and womb cancer are diagnosed too late to offer them any chance of effective treatment, claims German Cancer Aid. In an effort to address the situation, the society is sponsoring an initiative by Peter Altevogt from the Cancer Research Centre in Heidelberg (KFZH) and Mina Fogel from the Kaplan Hospital in Rehovot, Israel, to the tune of E194,000 ($196,000). The institutions have developed a new diagnostic method for cancer detection by identifying a protein that they believe could serve as a tumour marker.